Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Das Mikrobiom des Darms – Terra incognita.

Reinshagen M, Stallmach A.

Z Gastroenterol. 2019 Jul;57(7):833. doi: 10.1055/a-0916-2921. Epub 2019 Jul 9. German. No abstract available.

PMID:
31288279
2.

[A gut-brain neural circuit for nutrient sensory transduction].

Reinshagen M.

Z Gastroenterol. 2019 Mar;57(3):335. doi: 10.1055/a-0821-1865. Epub 2019 Mar 12. German. No abstract available.

PMID:
30861558
3.

Invitation to Screening Colonoscopy in the Population at Familial Risk for Colorectal Cancer.

Bauer A, Riemann JF, Seufferlein T, Reinshagen M, Hollerbach S, Haug U, Unverzagt S, Boese S, Ritter-Herschbach M, Jahn P, Frese T, Harris M, Landenberger M.

Dtsch Arztebl Int. 2018 Oct 26;115(43):715-722. doi: 10.3238/arztebl.2018.0715.

4.

ALIGNed on adherence: subanalysis of adherence in immune-mediated inflammatory diseases in the DACH region of the global ALIGN study.

Kolios AGA, Hueber AJ, Michetti P, Mrowietz U, Mustak-Blagusz M, Sator PG, Reinshagen M, Wilsmann-Theis D, Gomis-Kleindienst S, Luckey U, Rössler A, Schiefke I.

J Eur Acad Dermatol Venereol. 2019 Jan;33(1):234-241. doi: 10.1111/jdv.15179. Epub 2018 Aug 22.

5.

[Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial].

Reinshagen M, Stallmach A.

Z Gastroenterol. 2017 Aug;55(8):779-780. doi: 10.1055/s-0043-109349. Epub 2017 Aug 10. German. No abstract available.

PMID:
28799154
6.

The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease.

Harbord M, Annese V, Vavricka SR, Allez M, Barreiro-de Acosta M, Boberg KM, Burisch J, De Vos M, De Vries AM, Dick AD, Juillerat P, Karlsen TH, Koutroubakis I, Lakatos PL, Orchard T, Papay P, Raine T, Reinshagen M, Thaci D, Tilg H, Carbonnel F; European Crohn’s and Colitis Organisation.

J Crohns Colitis. 2016 Mar;10(3):239-54. doi: 10.1093/ecco-jcc/jjv213. Epub 2015 Nov 27. No abstract available.

7.

[Regulation of T-cell trafficking in chronic inflammatory disease--far more complex!].

Reinshagen M.

Z Gastroenterol. 2015 Sep;53(9):1108. doi: 10.1055/s-0035-1553203. Epub 2015 Sep 14. German. No abstract available.

PMID:
26367028
8.

A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis.

Miehlke S, Hruz P, Vieth M, Bussmann C, von Arnim U, Bajbouj M, Schlag C, Madisch A, Fibbe C, Wittenburg H, Allescher HD, Reinshagen M, Schubert S, Tack J, Müller M, Krummenerl P, Arts J, Mueller R, Dilger K, Greinwald R, Straumann A.

Gut. 2016 Mar;65(3):390-9. doi: 10.1136/gutjnl-2014-308815. Epub 2015 Mar 19.

9.

[Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease].

Reinshagen M.

Z Gastroenterol. 2015 Jan;53(1):53. doi: 10.1055/s-0034-1385651. Epub 2015 Jan 16. German. No abstract available.

PMID:
25594709
10.

Eosinophilic gastroenteritis with refractory ulcer disease and gastrointestinal bleeding as a rare manifestation of seronegative gastrointestinal food allergy.

Raithel M, Hahn M, Donhuijsen K, Hagel AF, Nägel A, Rieker RJ, Neurath MF, Reinshagen M.

Nutr J. 2014 Sep 17;13:93. doi: 10.1186/1475-2891-13-93.

11.

[S2k guidelines diverticular disease/diverticulitis].

Leifeld L, Germer CT, Böhm S, Dumoulin FL, Häuser W, Kreis M, Labenz J, Lembcke B, Post S, Reinshagen M, Ritz JP, Sauerbruch T, Wedel T, von Rahden B, Kruis W.

Z Gastroenterol. 2014 Jul;52(7):663-710. doi: 10.1055/s-0034-1366692. Epub 2014 Jul 15. German. No abstract available.

12.

[First-degree relatives of colorectal cancer patients: how many can we protect?].

Hollerbach S, Reinshagen M, Seufferlein T, Bauer A, Landenberger M, Riemann JF.

Z Gastroenterol. 2014 Mar;52(3):263. German. No abstract available.

PMID:
24761448
13.

[The enteric glia--part of the puzzle in Crohn's disease?].

von Boyen G, Reinshagen M.

Z Gastroenterol. 2011 Nov;49(11):1482-6. doi: 10.1055/s-0031-1281672. Epub 2011 Nov 8. Review. German.

PMID:
22069048
14.

[Updated German guideline on diagnosis and treatment of ulcerative colitis, 2011].

Dignass A, Preiss JC, Aust DE, Autschbach F, Ballauff A, Barretton G, Bokemeyer B, Fichtner-Feigl S, Hagel S, Herrlinger KR, Jantschek G, Kroesen A, Kruis W, Kucharzik T, Langhorst J, Reinshagen M, Rogler G, Schleiermacher D, Schmidt C, Schreiber S, Schulze H, Stange E, Zeitz M, Hoffmann JC, Stallmach A.

Z Gastroenterol. 2011 Sep;49(9):1276-341. doi: 10.1055/s-0031-1281666. Epub 2011 Aug 24. German. No abstract available.

PMID:
21866493
15.

Intravenous ibandronate or sodium-fluoride--a 3.5 years study on bone density and fractures in Crohn's disease patients with osteoporosis.

Klaus J, Reinshagen M, Herdt K, Adler G, von Boyen GB, von Tirpitz C.

J Gastrointestin Liver Dis. 2011 Jun;20(2):141-8.

16.

A single dose of intravenous zoledronate prevents glucocorticoid therapy-associated bone loss in acute flare of Crohn's disease, a randomized controlled trial.

Klaus J, Haenle MM, Schröter C, Adler G, von Boyen G, Reinshagen M, von Tirpitz C.

Am J Gastroenterol. 2011 Apr;106(4):786-93. doi: 10.1038/ajg.2011.59. Epub 2011 Mar 8.

PMID:
21386830
17.

Bones and Crohn's: no benefit of adding sodium fluoride or ibandronate to calcium and vitamin D.

Klaus J, Reinshagen M, Herdt K, Schröter C, Adler G, von Boyen GB, von Tirpitz C.

World J Gastroenterol. 2011 Jan 21;17(3):334-42. doi: 10.3748/wjg.v17.i3.334.

18.

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.

Van Assche G, Dignass A, Reinisch W, van der Woude CJ, Sturm A, De Vos M, Guslandi M, Oldenburg B, Dotan I, Marteau P, Ardizzone A, Baumgart DC, D'Haens G, Gionchetti P, Portela F, Vucelic B, Söderholm J, Escher J, Koletzko S, Kolho KL, Lukas M, Mottet C, Tilg H, Vermeire S, Carbonnel F, Cole A, Novacek G, Reinshagen M, Tsianos E, Herrlinger K, Oldenburg B, Bouhnik Y, Kiesslich R, Stange E, Travis S, Lindsay J; European Crohn's and Colitis Organisation (ECCO).

J Crohns Colitis. 2010 Feb;4(1):63-101. doi: 10.1016/j.crohns.2009.09.009. Epub 2009 Dec 21. No abstract available.

19.

Small intestinal bacterial overgrowth mimicking acute flare as a pitfall in patients with Crohn's Disease.

Klaus J, Spaniol U, Adler G, Mason RA, Reinshagen M, von Tirpitz C C.

BMC Gastroenterol. 2009 Jul 30;9:61. doi: 10.1186/1471-230X-9-61.

20.

Significant differences between Crohn's disease and ulcerative colitis regarding the impact of body mass index and initial disease activity on responsiveness to azathioprine: results from a European multicenter study in 1,176 patients.

Holtmann MH, Krummenauer F, Claas C, Kremeyer K, Lorenz D, Rainer O, Vogel I, Böcker U, Böhm S, Büning C, Duchmann R, Gerken G, Herfarth H, Lügering N, Kruis W, Reinshagen M, Schmidt J, Stallmach A, Stein J, Sturm A, Galle PR, Hommes DW, D'Haens G, Rutgeerts P, Neurath MF.

Dig Dis Sci. 2010 Apr;55(4):1066-78. doi: 10.1007/s10620-009-0846-9. Epub 2009 Jun 10.

PMID:
19513841
21.

Bones and Crohn's: estradiol deficiency in men with Crohn's disease is not associated with reduced bone mineral density.

Klaus J, Reinshagen M, Adler G, Boehm B, von Tirpitz C.

BMC Gastroenterol. 2008 Oct 23;8:48. doi: 10.1186/1471-230X-8-48.

22.

[Clinical practice guideline on diagnosis and treatment of Crohn's disease].

Hoffmann JC, Preiss JC, Autschbach F, Buhr HJ, Häuser W, Herrlinger K, Höhne W, Koletzko S, Krieglstein CF, Kruis W, Matthes H, Moser G, Reinshagen M, Rogler G, Schreiber S, Schreyer AG, Sido B, Siegmund B, Stallmach A, Bokemeyer B, Stange EF, Zeitz M.

Z Gastroenterol. 2008 Sep;46(9):1094-146. doi: 10.1055/s-2008-1027796. Epub 2008 Sep 22. German. No abstract available.

PMID:
18810679
23.

[Short version of the updated German S3 (level 3) guideline on diagnosis and treatment of Crohn's disease].

Hoffmann JC, Autschbach F, Bokemeyer B, Buhr HJ, Herrlinger K, Höhne W, Krieglstein C, Kruis W, Moser G, Preiss JC, Reinshagen M, Rogler G, Schreiber S, Schreyer AG, Siegmund B, Stallmach A, Stange EF, Zeitz M.

Dtsch Med Wochenschr. 2008 Sep;133(38):1924-9. doi: 10.1055/s-0028-1085580. Epub 2008 Sep 11. Review. German. No abstract available.

24.

Osteoporosis in inflammatory bowel disease.

Reinshagen M.

J Crohns Colitis. 2008 Sep;2(3):202-7. doi: 10.1016/j.crohns.2008.01.005. Epub 2008 Feb 14.

25.

6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial.

Reinshagen M, Schütz E, Armstrong VW, Behrens C, von Tirpitz C, Stallmach A, Herfarth H, Stein J, Bias P, Adler G, Shipkova M, Kruis W, Oellerich M, von Ahsen N.

Clin Chem. 2007 Jul;53(7):1306-14. Epub 2007 May 10.

26.

Nerve growth factor secretion in cultured enteric glia cells is modulated by proinflammatory cytokines.

von Boyen GB, Steinkamp M, Reinshagen M, Schäfer KH, Adler G, Kirsch J.

J Neuroendocrinol. 2006 Nov;18(11):820-5.

PMID:
17026531
27.

Long-term effectiveness of azathioprine in IBD beyond 4 years: a European multicenter study in 1176 patients.

Holtmann MH, Krummenauer F, Claas C, Kremeyer K, Lorenz D, Rainer O, Vogel I, Böcker U, Böhm S, Büning C, Duchmann R, Gerken G, Herfarth H, Lügering N, Kruis W, Reinshagen M, Schmidt J, Stallmach A, Stein J, Sturm A, Galle PR, Hommes DW, D'Haens G, Rutgeerts P, Neurath MF.

Dig Dis Sci. 2006 Sep;51(9):1516-24. Epub 2006 Aug 22.

PMID:
16927148
28.

Proinflammatory cytokines induce neurotrophic factor expression in enteric glia: a key to the regulation of epithelial apoptosis in Crohn's disease.

von Boyen GB, Steinkamp M, Geerling I, Reinshagen M, Schäfer KH, Adler G, Kirsch J.

Inflamm Bowel Dis. 2006 May;12(5):346-54.

PMID:
16670534
29.

Infliximab for ulcerative colitis.

Reinshagen M.

N Engl J Med. 2006 Mar 30;354(13):1424-6; author reply 1424-6. No abstract available.

PMID:
16575949
30.

Lack of correlation between the vitamin D receptor Fokl start codon polymorphism and bone mineral density in patients with Crohn's disease.

Bregenzer N, Schäffler A, Gelbmann CM, Steinkamp M, Reinshagen M, Schölmerich J, Andus T.

Exp Clin Endocrinol Diabetes. 2006 Jan;114(1):1-5.

PMID:
16450309
31.

Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis.

Kruis W, Dignass A, Steinhagen-Thiessen E, Morgenstern J, Mössner J, Schreiber S, Vecchi M, Malesci A, Reinshagen M, Löfberg R.

World J Gastroenterol. 2005 Nov 28;11(44):7001-6.

32.

Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.

Schröder O, Mickisch O, Seidler U, de Weerth A, Dignass AU, Herfarth H, Reinshagen M, Schreiber S, Junge U, Schrott M, Stein J.

Am J Gastroenterol. 2005 Nov;100(11):2503-9.

PMID:
16279906
33.

Association of inosine triphosphatase 94C>A and thiopurine S-methyltransferase deficiency with adverse events and study drop-outs under azathioprine therapy in a prospective Crohn disease study.

von Ahsen N, Armstrong VW, Behrens C, von Tirpitz C, Stallmach A, Herfarth H, Stein J, Bias P, Adler G, Shipkova M, Oellerich M, Kruis W, Reinshagen M, Schütz E.

Clin Chem. 2005 Dec;51(12):2282-8. Epub 2005 Oct 7. Erratum in: Clin Chem. 2006 Aug;52(8):1628. Schütz, Ekkehard [added].

34.

Diagnosis and management of osteoporosis in inflammatory bowel disease.

Reinshagen M, Von Tirpitz C.

Minerva Med. 2004 Dec;95(6):481-7. Review.

PMID:
15785433
35.

[Extraintestinal manifestations in ulcerative colitis].

Reinshagen M, Fölsch UR.

Z Gastroenterol. 2004 Sep;42(9):1024-8. German. No abstract available.

PMID:
15455279
36.

[Diagnosis and therapy of ulcerative colitis: results of an evidence based consensus conference by the German society of Digestive and Metabolic Diseases and the competence network on inflammatory bowel disease].

Hoffmann JC, Zeitz M, Bischoff SC, Brambs HJ, Bruch HP, Buhr HJ, Dignass A, Fischer I, Fleig W, Fölsch UR, Herrlinger K, Höhne W, Jantschek G, Kaltz B, Keller KM, Knebel U, Kroesen AJ, Kruis W, Matthes H, Moser G, Mundt S, Pox C, Reinshagen M, Reissmann A, Riemann J, Rogler G, Schmiegel W, Schölmerich J, Schreiber S, Schwandner O, Selbmann HK, Stange EF, Utzig M, Wittekind C.

Z Gastroenterol. 2004 Sep;42(9):979-83. Review. German. No abstract available.

PMID:
15455267
37.

[Intestinal wall vascularisation in Crohn's disease].

Kratzer W, Foeller T, Kaechele V, Reinshagen M, Tirpitz CV, Haenle MM.

Z Gastroenterol. 2004 Sep;42(9):973-8. German.

PMID:
15455266
38.

Thioguanine-nucleotides do not predict efficacy of tioguanine in Crohn's disease.

Herrlinger KR, Fellermann K, Fischer C, Kreisel W, Deibert P, Schoelmerich J, Fleig WE, Ruhl A, Reinshagen M, Greinwald R, Stange EF, Schwab M.

Aliment Pharmacol Ther. 2004 Jun 15;19(12):1269-76.

39.

Cost of outpatient care in patients with inflammatory bowel disease in a German University Hospital.

Ebinger M, Leidl R, Thomas S, Von Tirpitz C, Reinshagen M, Adler G, Konig HH.

J Gastroenterol Hepatol. 2004 Feb;19(2):192-9.

PMID:
14731130
40.

Proinflammatory cytokines increase glial fibrillary acidic protein expression in enteric glia.

von Boyen GB, Steinkamp M, Reinshagen M, Schäfer KH, Adler G, Kirsch J.

Gut. 2004 Feb;53(2):222-8.

41.

[Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association].

von Tirpitz C, Steder-Neukamm U, Glas K, Sander S, Ring C, Klaus J, Reinshagen M.

Z Gastroenterol. 2003 Dec;41(12):1145-50. German.

PMID:
14661123
42.

Osteoporosis and other extraintestinal symptoms and complications of inflammatory bowel diseases.

Reinshagen M, von Tirpitz C.

Dig Dis. 2003;21(2):138-45. Review. No abstract available.

PMID:
14571111
43.

Effect of systemic glucocorticoid therapy on bone metabolism and the osteoprotegerin system in patients with active Crohn's disease.

von Tirpitz C, Epp S, Klaus J, Mason R, Hawa G, Brinskelle-Schmal N, Hofbauer LC, Adler G, Kratzer W, Reinshagen M.

Eur J Gastroenterol Hepatol. 2003 Nov;15(11):1165-70.

PMID:
14560148
44.

Management of osteoporosis in patients with gastrointestinal diseases.

von Tirpitz C, Reinshagen M.

Eur J Gastroenterol Hepatol. 2003 Aug;15(8):869-76. Review.

PMID:
12867796
45.

[Comparison of conventional enteroclysis, intestinal ultrasound and MRI-enteroclysis for determining changes in the small intestine and complications in patients with Crohn's disease].

Schmidt T, Reinshagen M, Brambs HJ, Adler G, Rieber A, V Tirpitz C, Kratzer W.

Z Gastroenterol. 2003 Jul;41(7):641-8. German.

PMID:
12858235
46.

[Encoding patients with chronic inflammatory bowel diseases according to the German DRG system].

Reinshagen M, Hoffmann J, Adler G, Zeitz M; Arbeitsgruppe der Deutschen Gesellschaft für Verdaunngs- und Stoffwechselkrankheiten.

Z Gastroenterol. 2003 May;41(5):505-6. German. No abstract available.

PMID:
12822560
47.

Glial-derived neurotrophic factor regulates apoptosis in colonic epithelial cells.

Steinkamp M, Geerling I, Seufferlein T, von Boyen G, Egger B, Grossmann J, Ludwig L, Adler G, Reinshagen M.

Gastroenterology. 2003 Jun;124(7):1748-57.

PMID:
12806607
48.

NGF---not just a nerve growth factor in the gut.

Reinshagen M, Steinkamp M.

Am J Physiol Regul Integr Comp Physiol. 2003 May;284(5):R1322. No abstract available.

49.

Quantitative ultrasound of the proximal phalanges and dual-energy X-ray absorptiometry in Crohn's disease patients with osteopenia.

von Tirpitz C, Klaus J, Steinkamp M, Mason R, Kratzer W, Adler G, Rieber A, Reinshagen M.

J Gastroenterol. 2003;38(3):238-43.

PMID:
12673446
50.

Therapy of osteoporosis in patients with Crohn's disease: a randomized study comparing sodium fluoride and ibandronate.

von Tirpitz C, Klaus J, Steinkamp M, Hofbauer LC, Kratzer W, Mason R, Boehm BO, Adler G, Reinshagen M.

Aliment Pharmacol Ther. 2003 Mar 15;17(6):807-16.

Supplemental Content

Loading ...
Support Center